AEMD — Aethlon Medical Share News
0.000.00%
Last trade - 00:00Aethlon Medical surges on research partnership with NAMSA
Brief: Aethlon Medical Announces Contract With Namsa To Advance Hemopurifier Clinical Programs In Cancer
Aethlon Medical Inc reports results for the quarter ended in September - Earnings Summary
Brief: Aethlon Medical Announces Second Quarter Financial Results, Provides Corporate Update
Aethlon Medical Inc expected to post a loss of 21 cents a share - Earnings Preview
Brief: Aethlon Medical Inc - On Oct 25, Gets Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Mega-cap growth stocks, U.S. restaurants
U.S. STOCKS ON THE MOVE-Retail stocks, payment firms, travel stocks
U.S. STOCKS ON THE MOVE-Twitter, Nikola, Tesla, Xeris Biopharma
U.S. STOCKS ON THE MOVE-Twitter, Tesla, Trade Desk
Aethlon Medical surges after trial for potential monkeypox therapy
Brief: Aethlon Medical QTRLY Loss Per Share $0.19
Brief: Aethlon Medical Announces U.S. FDA Approval Of Hemopurifier Covid-19 Study Protocol Amendment
Aethlon Medical Inc reports results for the quarter ended in March - Earnings Summary
Brief: Aethlon Medical Announces Fiscal Year End Financial Results
Aethlon Medical Inc expected to post a loss of 14 cents a share - Earnings Preview
Aethlon Medical Inc expected to post a loss of 14 cents a share - Earnings Preview
Aethlon Medical up as substance used in blood purifier device binds COVID variants
Brief: Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding Of Seven Clinically Relevant Covid-19 Variants